Susan Young Rojahn

A View from Susan Young Rojahn

A Genetic Matchmaking Movie Isn't So Far-Fetched

An upcoming film, The Perfect 46, is about a fictional genomics company with a not-so-fictional idea.

  • September 26, 2013

What if finding “The One” meant finding the person whose genome is most compatible with your own?

That’s the question raised by an upcoming movie called The Perfect 46. Writer/director Brett Ryan Bonowicz presented a near-final version of the film on Wednesday night at the Consumer Genetics Conference in Boston. Self-driving cars and disposable electronic package trackers set the film in an unspecified year in the future, but one that isn’t so far away that you can’t find a VCR or bulky television set.

The story centers around a genome-analysis company, The Perfect 46, that has developed an algorithm to determine the likelihood of prospective parents having a child with genetic disease. The promise is that future generations could be free of single-gene disorders like cystic fibrosis or even complex diseases like diabetes, if only everyone would work together to prevent these conditions in their children.

Sure, it sounds a bit like Gattaca, but unlike that 1997 film, The Perfect 46 does not feel like it’s happening in some distant era. In fact, I was struck by how unfuturistic it all seemed.

The real genetic analysis startup GenePeeks already says it can help sperm bank clients avoid donors whose genetic material may cause disease when combined with their own (see “Genetic Screening Can Uncover Risky Matches at the Sperm Bank”). And for couples planning to have a baby together, Counsyl and GoodStart Genetics can screen one or both partners to see whether they carry any DNA variants that could cause disease if combined with a similar genetic problem (see “Better Screening for Deadly Genetic Diseases”).

I met Bonowicz at the conference and he agreed that his science-fiction film is not that far outside the realm of possibility. “Once I had the idea to write the film I realized I had to make it this year or not at all because a company is going to be doing this in four to five years,” he says.

On a very small scale, genetic matchmaking is already happening, albeit not led by a company but by families affected by the disease and concerned medical groups. In the last few decades, the number of children born with Tay-Sachs disease—a neurodegenerative disorder that often takes a child’s life by the age of five—has been reduced by 90 percent in North American Ashkenazi Jews. Bulldozing that disease depended on gene-savvy matchmakers and in utero testing.

Another difference from Gattaca is the lack of a committed stance to whether genetic screening is a good or bad idea. The film’s protagonist heralds his matchmaking algorithm as a way to eliminate disease, but the film also touches on some of the fears surrounding genetic screening in reproductive medicine: What is a genetic defect and what is valuable human variation? Who decides what is healthy and what is not? When is it okay to intervene? And what if the screening doesn’t go as planned? Bonowicz says he hopes that audiences will have conflicting opinions about the film. “I wanted to start a conversation,” he says. “That’s the only way to push forward.”

Bonowicz is looking to premiere a final version of the movie at a film festival next year.

Become an MIT Technology Review Insider for in-depth analysis and unparalleled perspective.

Subscribe today

Uh oh–you've read all of your free articles for this month.

Insider Premium
$179.95/yr US PRICE

More from Rewriting Life

Reprogramming our bodies to make us healthier.

Want more award-winning journalism? Subscribe and become an Insider.
  • Insider Premium {! insider.prices.premium !}*

    {! insider.display.menuOptionsLabel !}

    Our award winning magazine, unlimited access to our story archive, special discounts to MIT Technology Review Events, and exclusive content.

    See details+

    What's Included

    Bimonthly home delivery and unlimited 24/7 access to MIT Technology Review’s website.

    The Download. Our daily newsletter of what's important in technology and innovation.

    Access to the Magazine archive. Over 24,000 articles going back to 1899 at your fingertips.

    Special Discounts to select partner offerings

    Discount to MIT Technology Review events

    Ad-free web experience

    First Look. Exclusive early access to stories.

    Insider Conversations. Listen in as our editors talk to innovators from around the world.

  • Insider Plus {! insider.prices.plus !}* Best Value

    {! insider.display.menuOptionsLabel !}

    Everything included in Insider Basic, plus ad-free web experience, select discounts to partner offerings and MIT Technology Review events

    See details+

    What's Included

    Bimonthly home delivery and unlimited 24/7 access to MIT Technology Review’s website.

    The Download. Our daily newsletter of what's important in technology and innovation.

    Access to the Magazine archive. Over 24,000 articles going back to 1899 at your fingertips.

    Special Discounts to select partner offerings

    Discount to MIT Technology Review events

    Ad-free web experience

  • Insider Basic {! insider.prices.basic !}*

    {! insider.display.menuOptionsLabel !}

    Six issues of our award winning magazine and daily delivery of The Download, our newsletter of what’s important in technology and innovation.

    See details+

    What's Included

    Bimonthly home delivery and unlimited 24/7 access to MIT Technology Review’s website.

    The Download. Our daily newsletter of what's important in technology and innovation.

/
You've read all of your free articles this month. This is your last free article this month. You've read of free articles this month. or  for unlimited online access.